4 Dental Supplies Stocks Likely to Gain Amid Rising Tariff Risks
Here, we discuss four stocks from the Dental Supplies industry that are likely to generate wealth for investors amid tariff uncertainty. These are MCK, CAH, WST and COO.
Can Sustained Product Demand Drive CAH Stock Before Q4 Earnings?
The continued solid uptake of Cardinal Health's products is expected to have driven fiscal fourth-quarter revenues despite an uncertain macroeconomic environment.
What Analyst Projections for Key Metrics Reveal About Cardinal (CAH) Q4 Earnings
Beyond analysts' top-and-bottom-line estimates for Cardinal (CAH), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended June 2025.
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Why Investors Need to Take Advantage of These 2 Medical Stocks Now
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Top 5 Dividend Stocks Outperform Market Turmoil With Gains Up to 81.8% in 2025
Div idend stocks ha ve long been a mainstay for investors focused on reliable returns and consistent income.
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
Here is how Cardinal Health (CAH) and Biotricity Inc. (BTCY) have performed compared to their sector so far this year.
2 Stocks I Plan to Hold for the Next Decade and Beyond
Key Points in This Article: Holding onto stocks that have significantly appreciated, rather than cashing out for short-term gains, preserves long-term portfolio growth and avoids capital gains taxes.
Will Cardinal (CAH) Beat Estimates Again in Its Next Earnings Report?
Cardinal (CAH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Should Value Investors Buy Cardinal Health (CAH) Stock?
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cardinal Health (CAH) Stock Declines While Market Improves: Some Information for Investors
In the closing of the recent trading day, Cardinal Health (CAH) stood at $162.17, denoting a -1.27% move from the preceding trading day.
